Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.67 USD
+0.11 (20.00%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $0.64 -0.03 (-4.76%) 7:24 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | -22.73% |
ABR | 1.86 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.55 |
Next Year | -0.15 |
EPS (TTM) | -1.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.40M | 11.55M | 46.50M | 115.23M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 17.80M | 13.10M | 50.50M | 232.00M |
Low Estimate | 5.00M | 10.00M | 40.00M | 53.70M |
Year ago Sales | 6.84M | 9.40M | 176.23M | 46.50M |
Year over Year Growth Est. | 66.67% | 22.87% | -73.61% | 147.81% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.11 | -0.55 | -0.15 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.17 | -0.11 | -0.40 | -0.09 |
High Estimate | -0.09 | -0.09 | -0.40 | 0.21 |
Low Estimate | -0.20 | -0.12 | -0.77 | -0.62 |
Year ago EPS | -0.37 | -0.34 | -0.59 | -0.55 |
Year over Year Growth Est. | 56.76% | 67.65% | 6.78% | 71.82% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.11 | -0.55 | -0.15 |
7 Days Ago | -0.16 | -0.11 | -0.55 | -0.15 |
30 Days Ago | -0.16 | -0.11 | -0.55 | -0.15 |
60 Days Ago | -0.15 | -0.12 | -0.53 | -0.22 |
90 Days Ago | -0.14 | -0.13 | -0.54 | -0.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.11 | -0.55 | -0.15 |
Zacks Consensus Estimate | -0.16 | -0.11 | -0.55 | -0.15 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.34 | -0.34 | -0.37 | NA |
Estimate | -0.22 | -0.25 | -0.33 | -0.35 | NA |
Difference | -0.05 | -0.09 | -0.01 | -0.02 | -0.04 |
Surprise | -22.73% | -36.00% | -3.03% | -5.71% | -16.87% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more